FDA has accepted and granted priority review to the New Drug Application for asciminib (ABL001) in chronic myeloid leukemia.
Phil and Penny Knight made a record-setting $2 billion gift to OHSU Knight Cancer Institute.
FDA grants priority review for NDA of asciminib in CML indication
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
In the last three years of her life, Andrea Werblin Reid wrote 150 poems on living with ovarian cancer and end of life. Werblin Reid died of ovarian cancer in 2022. Her third collection of poetry, “To See Yourself As You Vanish,” will be published Sept. 9.
Mary Beckerle, a whitewater kayaker, has advice for all the folks in the cancer field: never catastrophize, never panic.
I always liked poetry, but I was never a poet. I had to marry into that.
I write a weekly blog for Georgetown University’s Lombardi Comprehensive Cancer Center community. Here I share an updated version of a blog post I wrote in September 2024, now supplemented by some poems I have written over the years that inspired paintings by my wife Harriet Weiner, who is a much better artist than I am a poet or writer.
Earlier this year, amid efforts by the Trump administration to reduce the federal workforce, Lakshmi Grama decided to take early retirement from NCI.
